Sign in with Google
bullish
MegaRobo: China-Based Disruptor in Life Science Automation
369 Views31 Oct 2022 08:28
SUMMARY
- MegaRobo is a leader in life science automation, founded in 2016 by CEO Daniel Huang and CMO Zhixin Qiao. The company reached a unicorn valuation of $1B+ in 2022.
- MegaRobo wants to improve the efficiency of life sciences research by using robotics and AI technology. In June 2022, AI and robotics unicorn closed the $300M Series C round.
- Using AI in R&D drug discovery is gaining traction. The global lab automation market is a ~$5B opportunity and is expected to reach ~$9.4B by 2030.
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Toyota Industries (6201) - Thinking About How To Value a ¥6trln Bid
- Hainan Meilan Intl Airport (357 HK): Hainan SASAC's Left/Right Pocket MGO
- StubWorld: On Valuing Toyota Industries (6201)'s Stub Ops
- Meilan Airport (357 HK): Possible Unconditional MGO at HK$10.62
- Shibaura Elec (6957) - Minebea Overbids Yageo's Overbid of Minebea's Overbid of Yageo - ¥5,500
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- MegaRobo: China-Based Disruptor in Life Science Automation31 Oct 2022
x